Study Finds Colorectal Cancer Immunochemical Screening Reduces Mortality Rates in the US

A recent study published in the JAMA Network Open, a prestigious medical journal, has found that the Fecal Immunochemical Test, a screening test for colorectal cancer, can effectively reduce the mortality rate of the disease. This discovery has drawn attention from the global medical community.

The JAMA Network Open, established in 2018 and published by the American Medical Association, covers all aspects of biomedical science. The journal's inaugural editor-in-chief was Fred Rivara from the University of Washington, and since 2024, Eli Perencevich from the University of Iowa has taken over the position. The journal is primarily funded through article processing fees, and most of its articles are protected under a Creative Commons license. The journal also provides Spanish and Chinese translations of its articles and abstracts. According to the Journal Citation Reports, the journal had an impact factor of 13.353 in 2021, ranking 15th among national medical and internal medicine journals, and fifth among all open-access journals.

A study conducted in the United States found that regular use of the Fecal Immunochemical Test can reduce the mortality rate of colorectal cancer by 1 to 2 deaths per 100,000 people screened. The study's results indicate that the test plays a crucial role in preventing colorectal cancer. However, medical experts warn that the test is not foolproof and that individuals should still closely monitor their health and follow medical guidelines.

Researchers further emphasize that the Fecal Immunochemical Test should be widely promoted and combined with other early screening methods to provide effective prevention against colorectal cancer. This finding provides valuable guidance and momentum for promoting global health security and reducing mortality rates from colorectal cancer.

The medical community and public health experts believe that promoting and popularizing the Fecal Immunochemical Test can significantly reduce mortality rates from colorectal cancer. However, implementing this measure also requires matching medical resources, human resources, and funding demands. The study's results will continue to receive widespread attention and are considered to provide important research leads and references for global public health.

For Taiwan, the study's results provide important clues for the prevention and treatment of colorectal cancer. Taiwan can adopt effective screening measures and public health policies to reduce the mortality rate of colorectal cancer in its public health policies and medical practices.